Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Announcing Dr. Tomi Sawyer as Keynote Speaker at CHI’s Structure-Based Drug Design ConferenceDrugging the Undruggable: Transforming Nature’s α-Helix into Breakthrough Medicines will be discussed at CHI's 13th Annual Structure-Based Drug Design Conference this coming June.
The theme of the event is ‘Genome to Drug Lead with Big Data Approach' and Dr. Tomi Sawyer will be presenting on Thursday, June 20 at 8:40 a.m. about advancements in stapled peptide technology to transform Nature’s α-helix into breakthrough medicines. A major challenge of drug discovery has been to successfully modulate the biological properties of those therapeutic targets deemed “undruggable” Dr. Sawyer is currently Chief Scientific Officer, SVP Discovery & Innovative Technologies, Aileron Therapeutics (Cambridge, Mass.). He was previously Senior Director, Pfizer Research Technology Center (Cambridge, Mass.) and concurrently served on Pfizer’s Global Chemistry Leadership Team. In this capacity, Dr. Sawyer was responsible for drug discovery at the Cambridge facility, as well as global chemistry initiatives such as kinase-targeted innovative technologies. Prior to his tenure at Pfizer, he held several leadership positions in drug discovery at ARIAD Pharmaceuticals, including Senior Vice-President, Drug Discovery. He began his career at The Upjohn Company as a peptide chemistry and drug design scientist before moving on to a position at Parke-Davis/ Dr. Sawyer currently holds academic and research advisory appointments at the University of Massachusetts Medical School, Worcester and the University of Massachusetts, Amherst. Dr. Sawyer received a B.S. with Honors in chemistry from Moorhead State University and a Ph.D. with Distinction in organic chemistry from the University of Arizona. For more details and to register for this conference, visit http://www.healthtech.com/ To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com. Writers and editors are invited to attend. To request a press pass, contact Lisa Scimemi at lscimemi@healthtech.com. About Cambridge Healthtech Institute (chicorporate.com) Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine. Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. About Bio-IT World: (bio-itworld.com) Part of the Cambridge Healthtech Institute Media Group (chimediagroup.com (http://www.chimediagroup.com)) Contact: James Prudhomme Cambridge Healthtech Institute 781-972-5400 jprudhomme@healthtech.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|